Printer Friendly

Valeant awarded US FDA 510(k) approval for the VICTUS Femtosecond Laser Platform for laser-assisted lens fragmentation during cataract surgery.

M2 EQUITYBITES-July 18, 2014-Valeant awarded US FDA 510(k) approval for the VICTUS Femtosecond Laser Platform for laser-assisted lens fragmentation during cataract surgery

(C)2014 M2 COMMUNICATIONS http://www.m2.com

Specialist pharmaceutical company Valeant Pharmaceuticals International (NYSE:VRX)(TSX:VRX) reported on Thursday the receipt of 510(k) clearance in the US for the VICTUS Femtosecond Laser Platform for laser-assisted lens fragmentation during cataract surgery.

This approval was awarded to the company's wholly owned subsidiary, Bausch + Lomb, by the US Food and Drug Administration (US FDA).

The company added that the fragmentation procedure follows a capsulotomy and uses the femtosecond laser to split the cataractous lens into sections. This is followed by phacoemulsification for cataract removal. The VICTUS platform offers different lens fragmentation patterns depending on the cataract grade and user preference.

VICTUS platforms is one of the only femtosecond lasers in the US with clearance for the creation of a corneal flap in patients undergoing LASIK surgery, anterior capsulotomy during cataract surgery, penetrating arcuate cuts/incisions in the cornea and laser-assisted lens fragmentation during cataract surgery, concluded the company.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jul 18, 2014
Words:192
Previous Article:ZS Pharma receives USD20m in debt financing from MidCap Financial.
Next Article:Consolidated Tomoka acquires building in Florida for about USD5.3m.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters